VIVIMEDLAB

Vivimed Labs Share Price

 

Stock touched 52W low

 

Start SIP in VIVIMEDLAB

Start SIP

Performance

  • Low
  • ₹11
  • High
  • ₹11
  • 52 Week Low
  • ₹11
  • 52 Week High
  • ₹29
  • Open Price₹11
  • Previous Close₹11
  • Volume1,461
  • 50 DMA₹12.21
  • 100 DMA₹11.31
  • 200 DMA₹11.80

Investment Returns

  • Over 1 Month + 951%
  • Over 3 Month + 951%
  • Over 6 Month + 951%
  • Over 1 Year + 951%

Smart Investing Starts Here Start SIP with Vivimed Labs for Steady Growth!

Invest Now

Vivimed Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -3.6
  • PEG Ratio
  • -0.2
  • Market Cap Cr
  • 87
  • P/B Ratio
  • -1.2
  • Average True Range
  • 1.46
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.99
  • RSI
  • 42.66
  • MFI
  • -

Vivimed Labs Financials

Vivimed Labs Technicals

EMA & SMA

Current Price
₹10.51
-0.55 (-4.97%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹14.16
  • 50 Day
  • ₹12.21
  • 100 Day
  • ₹11.31
  • 200 Day
  • ₹11.80

Resistance and Support

11.06 Pivot Speed
  • R3 11.06
  • R2 11.06
  • R1 11.06
  • S1 11.06
  • S2 11.06
  • S3 11.06

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vivimed Labs has an operating revenue of Rs. 104.12 Cr. on a trailing 12-month basis. An annual revenue de-growth of -24% needs improvement, Pre-tax margin of -27% needs improvement, NULL The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 10% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 20 which is a POOR score indicating inconsistency in earnings, a RS Rating of 97 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 69 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has some strength but we want to see some buyer interest and further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vivimed Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results, Pref. issue & A.G.M.
2025-05-30 Audited Results
2025-02-14 Quarterly Results
2025-01-10 Quarterly Results & Others To consider other business matters.

Vivimed Labs F&O

Vivimed Labs Shareholding Pattern

7.77%
1.64%
65.17%
25.42%

About Vivimed Labs

  • NSE Symbol
  • VIVIMEDLAB
  • BSE Symbol
  • 532660
  • Managing Director
  • Mr. Santosh Varalwar
  • ISIN
  • INE526G01021

Similar Stocks to Vivimed Labs

Vivimed Labs FAQs

Vivimed Labs share price is ₹10 As on 09 January, 2026 | 09:13

The Market Cap of Vivimed Labs is ₹87.1 Cr As on 09 January, 2026 | 09:13

The P/E ratio of Vivimed Labs is -3.6 As on 09 January, 2026 | 09:13

The PB ratio of Vivimed Labs is -1.2 As on 09 January, 2026 | 09:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23